SAK3 may offer hope to Alzheimer’s disease patients

Alzheimer; News from the web:

It is the name of a new drug, developed by the Japanese research group led by Tohoku University Professor Kohji Fukunaga. SAK3, stimulates the release of acetylcholine in the brain and improves cognition by activating the memory molecule CaMKII. According to Professor Fukunaga, SAK3 also reduces the production of amyloid beta protein in the study’s model mice.

Read all about it HERE